NCT04271059 is a clinical trial in Brain Injuries, Traumatic, sponsored by Kevin Hatton.

Who is sponsoring NCT04271059?

NCT04271059 is sponsored by Kevin Hatton.

What condition does NCT04271059 study?

NCT04271059 studies Brain Injuries, Traumatic.

Is NCT04271059 still recruiting?

NCT04271059 is currently terminated. Last updated 28 October 2021.

Last reviewed 2021-10-28 · How we verify

NCT04271059

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Platelet Bioenergetics in TBI

Terminated Last updated 28 October 2021

What this trial tests

trial in Brain Injuries, Traumatic in 1 participant. Terminated before completion.

Timeline

13 February 2020

Primary endpoint
13 February 2020

13 February 2020

Quick facts

Lead sponsor	Kevin Hatton
Status	Terminated
Study type	OBSERVATIONAL
Enrollment	1
Start date	13 February 2020
Primary completion	13 February 2020
Estimated completion	13 February 2020
Sites	1 location across United States

Conditions studied

Brain Injuries, Traumatic — all drugs for Brain Injuries, Traumatic →

Sponsor

Kevin Hatton

Who can join

Adults 18 to 50, any sex, with Brain Injuries, Traumatic. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This is a prospective study enrolling 5 patients with a diagnosis of traumatic brain injury (TBI) without polytrauma and 5 patients with TBI with polytrauma admitted to the University of Kentucky (UK) Chandler Medical Center to evaluate differences in platelet bioenergetics in the populations. Additionally, five healthy subjects will be recruited to the control group.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Brain Injuries, Traumatic

Currently open trials in the same condition.

NCT06898242 — Early Myofascial Manual Treatment in Subjects With Spasticity Following Acquired Brain Injury · NA · active not recruiting
NCT06413173 — Remotely Supervised tDCS+ for Complex Attention in mTBI (Cognetric) · NA · recruiting
NCT06142435 — mTBI Identification and Monitoring Through Retinal Scanning · recruiting
NCT05117619 — The HOME Program for Individuals With Traumatic Brain Injury and Family Members · NA · recruiting
NCT05092295 — Head and Intraocular Trauma Tool for the Identification of Mild Traumatic Brain Injury · active not recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT04271059 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Kevin Hatton
Last refreshed: 28 October 2021

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04271059.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing